Sovereign Wrongs: Ethics in the Governance of Pathogenic Genetic Resources

Ethics in Biology, Engineering and Medicine 3 (1-3):97-114 (2012)
  Copy   BIBTEX

Abstract

Genetic resources are a key resource for much biomedical research. Pathogenic genetic resources are of value in the identification, surveillance, understanding, and development of vaccines, treatments, and other responses to major public threats such as pandemic influenza outbreaks. Significant attempts have been made to improve the international governance of infectious disease over the last decade, but the handling of pathogenic genetic resources remains contentious and problematic. The need to address the deficiencies in current arrangements (e.g., the World Health Organization's Pandemic Influenza Preparedness Framework) is urgent because future outbreaks are likely to revert to the past situation in which developed states secured vaccine supplies for their own populations while leaving developing countries vulnerable to the pandemic. Thereby, the collaboration of developed countries with vital international systems such as the Global Influenza Surveillance and Response System is disincentivized. The current international approach to pathogenic genetic resources is based on the sovereign rights of states and access and benefit-sharing arrangements that stem from those rights. While this approach is consistent with international rules on other types of genetic resources, herein I argue that this is an inappropriate approach to pathogens on both political (serving public health goals) and ethical grounds (e.g., equity and justice). Instead I argue for a (modified) common heritage approach to pathogenic genetic resources, based on their intrinsic qualities (e.g., rapid mutation, easy transmissibility) and their value to global efforts to respond to disease outbreaks. I will further argue for de-linking access to these resources from benefit-sharing requirements; explaining that while there are strong justifications for both, their linkage (particularly for pathogenic genetic resources) is problematic and detrimental to the achievement of its intended goals (i.e., ensuring equitable benefit-sharing in return for access being granted).

Other Versions

No versions found

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 100,793

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

What is Fair and Equitable Benefit-sharing?Bram De Jonge - 2011 - Journal of Agricultural and Environmental Ethics 24 (2):127-146.
Benefit sharing: From obscurity to common knowledge.Doris Schroeder - 2006 - Developing World Bioethics 6 (3):135-143.

Analytics

Added to PP
2014-02-02

Downloads
26 (#835,533)

6 months
5 (#1,012,768)

Historical graph of downloads
How can I increase my downloads?

References found in this work

No references found.

Add more references